Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its User Group Meetings will be held in Asia, Europe, and North America during the fall 2012. Annual meetings bring together scientists, lab heads, bioinformaticians, and research IT managers from leading pharmaceutical and biotechnology companies, academic institutions, and contract research organizations. The sessions, which feature industry experts and forward-thinking customer presentations, explore the latest developments in high-throughput screening (HTS), high content screening (HCS), and label-free and Ion Channel data analysis.
“I am proud to say that Genedata Screener® has become the de facto standard for screening laboratories that value very fast and efficient data analysis for a variety of screening applications,” said Dr. Othmar Pfannes, CEO of Genedata. “This year’s User Group Meetings, conducted across three continents, validate Screener’s global adoption and we are delighted to provide forums in which leading scientists can network, learn and discuss about the latest developments in different screening technologies and applications."
The 2012 Genedata Screener User Group Meetings will offer workshops and training sessions on topics such as: from raw data to high-quality hit lists; analyzing Ion Channel experiments; selecting features in HCS assays; and conducting batch workflows. Meetings will be held in: Tokyo, Japan (Sept. 13); Boston, MA (Oct. 23); San Francisco, CA (Oct. 25); and Basel, Switzerland (Nov. 6). Inquiries may be sent to: email@example.com.
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. www.genedata.com.
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.